AU Stock MarketDetailed Quotes

PYCDA PYC Therapeutics Ltd

Watchlist

1.850
0.0000.00%

20min DelayMarket Closed Nov 25 16:00 AET

863.22MMarket Cap-19.27P/E (Static)

PYC Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

Operating cash flow (direct method)

Cash income from operating activities

116.66%20.96M

59.42%9.67M

94.11%6.07M

27.82%3.13M

2.45M

Income from government grants

----

27.27%70K

10.00%55K

--50K

Other cash income from operating activities

116.66%20.96M

61.29%9.67M

95.30%6M

28.19%3.07M

--2.4M

Cash paid

-75.41%-59.88M

-22.59%-34.14M

-85.52%-27.85M

-79.68%-15.01M

-8.35M

Payments to suppliers for goods and services

-75.41%-59.88M

-22.59%-34.14M

-85.52%-27.85M

-79.68%-15.01M

---8.35M

Direct interest paid

-79.97%-49.37K

15.10%-27.43K

16.77%-32.31K

9.55%-38.82K

---42.92K

Direct interest received

444.65%386.42K

142.07%70.95K

-77.72%29.31K

-35.03%131.53K

--202.44K

Operating cash flow

-58.01%-38.59M

-12.12%-24.42M

-84.73%-21.78M

-105.12%-11.79M

---5.75M

Investing cash flow

Cash flow from continuing investing activities

35.65%-307.04K

-101.46%-477.12K

310.55%32.68M

-12.70%-15.52M

-13.77M

Net PPE purchase and sale

37.48%-307.04K

-26.93%-491.12K

34.54%-386.91K

-457.07%-591.03K

---106.1K

Net other investing changes

----

-99.96%14K

321.47%33.07M

-9.25%-14.93M

---13.67M

Cash from discontinued investing activities

Investing cash flow

35.65%-307.04K

-101.46%-477.12K

310.55%32.68M

-12.70%-15.52M

---13.77M

Financing cash flow

Cash flow from continuing financing activities

688.34%90.19M

6,373.77%11.44M

-100.47%-182.36K

53.55%38.56M

25.11M

Net common stock issuance

675.15%90.49M

--11.67M

----

53.57%38.78M

--25.26M

Net other financing activities

-26.50%-294.49K

-27.65%-232.79K

19.54%-182.36K

-56.09%-226.64K

---145.2K

Cash from discontinued financing activities

Financing cash flow

688.34%90.19M

6,373.77%11.44M

-100.47%-182.36K

53.55%38.56M

--25.11M

Net cash flow

Beginning cash position

-46.51%15.57M

57.90%29.11M

154.55%18.44M

335.80%7.24M

--1.66M

Current changes in cash

481.18%51.3M

-225.59%-13.46M

-4.71%10.72M

101.17%11.24M

--5.59M

Effect of exchange rate changes

105.61%4.52K

-98.08%-80.65K

21.70%-40.72K

-456.54%-52K

---9.34K

End cash Position

329.47%66.87M

-46.51%15.57M

57.90%29.11M

154.55%18.44M

--7.24M

Free cash from

-56.13%-38.9M

-12.38%-24.91M

-79.04%-22.17M

-111.50%-12.38M

---5.85M

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020
Operating cash flow (direct method)
Cash income from operating activities	116.66%20.96M	59.42%9.67M	94.11%6.07M	27.82%3.13M	2.45M
Income from government grants	----	----	27.27%70K	10.00%55K	--50K
Other cash income from operating activities	116.66%20.96M	61.29%9.67M	95.30%6M	28.19%3.07M	--2.4M
Cash paid	-75.41%-59.88M	-22.59%-34.14M	-85.52%-27.85M	-79.68%-15.01M	-8.35M
Payments to suppliers for goods and services	-75.41%-59.88M	-22.59%-34.14M	-85.52%-27.85M	-79.68%-15.01M	---8.35M
Direct interest paid	-79.97%-49.37K	15.10%-27.43K	16.77%-32.31K	9.55%-38.82K	---42.92K
Direct interest received	444.65%386.42K	142.07%70.95K	-77.72%29.31K	-35.03%131.53K	--202.44K
Operating cash flow	-58.01%-38.59M	-12.12%-24.42M	-84.73%-21.78M	-105.12%-11.79M	---5.75M
Investing cash flow
Cash flow from continuing investing activities	35.65%-307.04K	-101.46%-477.12K	310.55%32.68M	-12.70%-15.52M	-13.77M
Net PPE purchase and sale	37.48%-307.04K	-26.93%-491.12K	34.54%-386.91K	-457.07%-591.03K	---106.1K
Net other investing changes	----	-99.96%14K	321.47%33.07M	-9.25%-14.93M	---13.67M
Cash from discontinued investing activities
Investing cash flow	35.65%-307.04K	-101.46%-477.12K	310.55%32.68M	-12.70%-15.52M	---13.77M
Financing cash flow
Cash flow from continuing financing activities	688.34%90.19M	6,373.77%11.44M	-100.47%-182.36K	53.55%38.56M	25.11M
Net common stock issuance	675.15%90.49M	--11.67M	----	53.57%38.78M	--25.26M
Net other financing activities	-26.50%-294.49K	-27.65%-232.79K	19.54%-182.36K	-56.09%-226.64K	---145.2K
Cash from discontinued financing activities
Financing cash flow	688.34%90.19M	6,373.77%11.44M	-100.47%-182.36K	53.55%38.56M	--25.11M
Net cash flow
Beginning cash position	-46.51%15.57M	57.90%29.11M	154.55%18.44M	335.80%7.24M	--1.66M
Current changes in cash	481.18%51.3M	-225.59%-13.46M	-4.71%10.72M	101.17%11.24M	--5.59M
Effect of exchange rate changes	105.61%4.52K	-98.08%-80.65K	21.70%-40.72K	-456.54%-52K	---9.34K
End cash Position	329.47%66.87M	-46.51%15.57M	57.90%29.11M	154.55%18.44M	--7.24M
Free cash from	-56.13%-38.9M	-12.38%-24.91M	-79.04%-22.17M	-111.50%-12.38M	---5.85M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Heat List

Overall

No Data